JMD Properties Inc
Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company's technology informs gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for dis… Read more
JMD Properties Inc (SLDX) - Net Assets
Latest net assets as of March 2025: $-19.42 Million USD
Based on the latest financial reports, JMD Properties Inc (SLDX) has net assets worth $-19.42 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($356.15K) and total liabilities ($19.77 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-19.42 Million |
| % of Total Assets | -5451.57% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
JMD Properties Inc - Net Assets Trend (2013–2024)
This chart illustrates how JMD Properties Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for JMD Properties Inc (2013–2024)
The table below shows the annual net assets of JMD Properties Inc from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-18.77 Million | -7.05% |
| 2023-12-31 | $-17.53 Million | +20.47% |
| 2022-12-31 | $-22.04 Million | +89.67% |
| 2021-12-31 | $-213.46 Million | -1924.25% |
| 2020-12-31 | $-10.55 Million | -88.26% |
| 2019-12-31 | $-5.60 Million | -23.38% |
| 2018-12-31 | $-4.54 Million | -738.41% |
| 2017-12-31 | $-541.51K | -37.70% |
| 2015-12-31 | $-393.24K | -0.81% |
| 2014-12-31 | $-390.10K | -203615.60% |
| 2013-12-31 | $-191.49 | -- |
Equity Component Analysis
This analysis shows how different components contribute to JMD Properties Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 23004959601.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $40.16K | % |
| Other Components | $211.24 Million | % |
| Total Equity | $-18.77 Million | 100.00% |
JMD Properties Inc Competitors by Market Cap
The table below lists competitors of JMD Properties Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bellevue Life Sciences Acquisition Corp. Warrant
NASDAQ:BLACW
|
$470.20 |
|
Trail Blazer Capital Corp.
V:TBLZ-P
|
$470.24 |
|
Coro Energy PLC
LSE:CORO
|
$470.51 |
|
Verify Smart Corp
PINK:VSMR
|
$470.56 |
|
EYANG HOLDINGS
BE:4EY
|
$469.38 |
|
Asim Textile Mills Ltd
KAR:ASTM
|
$469.20 |
|
GKS GieKSa Katowice SA
WAR:GKS
|
$468.49 |
|
Fletcher King Plc
LSE:FLK
|
$467.77 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JMD Properties Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -17,532,982 to -18,768,648, a change of -1,235,666.
- Net loss of 1,235,666 reduced equity.
- Other comprehensive income increased equity by 40,159.
- Other factors decreased equity by 40,159.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.24 Million | -6.58% |
| Other Comprehensive Income | $40.16K | +0.21% |
| Other Changes | $-40.16K | -0.21% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares JMD Properties Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $-5.59 | $0.05 | x |
| 2014-12-31 | $-4.58 | $0.05 | x |
| 2015-12-31 | $-2.71 | $0.05 | x |
| 2017-12-31 | $-187616.51 | $0.05 | x |
| 2018-12-31 | $-2355.64 | $0.05 | x |
| 2019-12-31 | $-0.06 | $0.05 | x |
| 2020-12-31 | $-0.11 | $0.05 | x |
| 2021-12-31 | $-2.22 | $0.05 | x |
| 2022-12-31 | $-0.13 | $0.05 | x |
| 2023-12-31 | $-0.06 | $0.05 | x |
| 2024-12-31 | $-0.05 | $0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently JMD Properties Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-238.82 |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-159.57K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.92K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $55.96K |
| 2018 | 0.00% | -1239.81% | 0.24x | 0.00x | $-1.35 Million |
| 2019 | 0.00% | -17985.02% | 0.01x | 0.00x | $-521.66K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $792.47K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $4.71 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.44 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.95 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $641.20K |
Industry Comparison
This section compares JMD Properties Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JMD Properties Inc (SLDX) | $-19.42 Million | 0.00% | N/A | $469.67 |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |